biostudies-literatureUnknown12(1)Corren JERJ open researchhttps://www.ebi.ac.uk/biostudies/studies/S-EPMC12926823biostudies-literatureFRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthmaPMC12926823Cameron-Christie SKell CRytelewski MBelvisi MWilliams AGeorgi BLindqvist EPlatt ABrooks DJimenez EMoate RSadiq MReid FPandya HCorren JMuthas DfalseFRONTIER-3: a randomised phase 2a study to investigate tozorakimab, an anti-interleukin-33 monoclonal antibody, in early-onset asthma2026-01-01T00:00:00Z2026 Jan2026-07-16T18:33:32.603Z2026-07-11T03:08:19.254ZS-EPMC12926823